Real-world treatment patterns and clinical outcomes among elderly patients with locoregionally advanced head and neck squamous cell carcinoma in the United States

In elderly patients with LA HNSCC, surgery followed by RT and definitive RT+ST were the most common treatment modalities in the resected and unresected cohorts, respectively. The suboptimal real-world survival of both groups highlights the significant unmet need for more effective therapies. The positive associations between rwEFS and rwOS in both the resected and unresected cohorts support EFS as a predictor of OS when OS data are immature in LA HNSCC.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2025-09-10
DOI
https://doi.org/10.3389/fonc.2025.1606990
Citations
1
Primary Topic
Head and Neck Cancer Studies
Type
article
Field-Weighted Citation Impact
1.85

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-world treatment patterns and clinical outcomes among elderly patients with locoregionally advanced head and neck squamous cell carcinoma in the United States

Yuexin Tang, Nati Lerman, Glenn J. Hanna, Yan Song et al.
1 citations
Frontiers in Oncology
Head and Neck Cancer Studies
1.85
article

Real-world treatment patterns and clinical outcomes among elderly patients with locoregionally advanced head and neck squamous cell carcinoma in the United States

Yuexin Tang, Nati Lerman, Glenn J. Hanna, Yan Song, James Signorovitch, Behzad Bidadi, Sanjay Merchant, Dandan Zheng, Jiayang Li, Rui Song, Su Zhang, Anyu Zhu
article en
1 citations

Abstract

In elderly patients with LA HNSCC, surgery followed by RT and definitive RT+ST were the most common treatment modalities in the resected and unresected cohorts, respectively. The suboptimal real-world survival of both groups highlights the significant unmet need for more effective therapies. The positive associations between rwEFS and rwOS in both the resected and unresected cohorts support EFS as a predictor of OS when OS data are immature in LA HNSCC.

Frontiers in OncologyVol. 15
Merck & Co., Inc., Rahway, NJ, USA (United States) (US), Dana-Farber Cancer Institute (US), Analysis Group (United States) (US)
California Department of Public Health, University of Southern California, Centers for Disease Control and Prevention, University of California, San Francisco, National Cancer Institute
Openalex Percentile: Top 12%
Head and Neck Cancer Studies
1.85
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Real-world treatment patterns and clinical outcomes among elderly patients with locoregionally advanced head and neck squamous cell carcinoma in the United States — Yuexin Tang, Nati Lerman, et al. · Frontiers in Oncology (2025) | TGRS Research Map | TGRS